Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Tammuella Singleton, MD
Healthcare Provider Chief, Pediatric Hematology
Louisiana Center for Advanced Medicine
2053 Gause Blvd E, Suite 200
Slidell, Louisiana, United States
Dr. Singleton serves as a pediatric hematologist, Division Chief, Pediatric Hematology, and Director of MCAM’s Hemophilia Treatment Center. Dr. Singleton will work out of MCAM’s new Slidell, Louisiana office location and will focus on serving children and adults with hemophilia and sickle cell disease across Louisiana and the Mississippi coast.
Prior to joining MCAM, she spent six years at Louisiana State University School of Medicine/Children’s Hospital of New Orleans in their pediatric hematology/oncology division. Dr. Singleton has also held positions in Tulane’s pediatric hematology division, the Sickle Cell Center of Southern Louisiana, and the Louisiana Center for Bleeding and Clotting Disorders. Dr. Singleton has authored numerous publications, served as an expert speaker around the world, and as the principal investigator on numerous studies pertaining to hemophilia. Dr. Singleton treats adults and children with rare hematological conditions with a focus on transitional care. She also has significant training and expertise in musculoskeletal ultrasound in hemophilia patients. She is currently an Ambassador for the American Society of Hematology.
Related Content
-
Hatoon Ezzat, MBBS, FRCPC, ABIMDr. Hatoon Ezzat received her medical de...
-
Sickle Cell Disease Association of North TexasSCDA Tarrant is committed to providing m...
-
Pediatric to adult care co-location transitional model for youth with sickle cell diseaseSurvival to adulthood for children with ...
-
Children’s Hospital of WisconsinThe Sickle Cell Research Program at Chil...
-
Ashley Singleton, MPHAshley Singleton is a Program and Resear...
-
University of North Carolina at Chapel Hill School of Medicine, Division of Hematology/OncologyThe Division of Hematology/Oncology offe...
-
GBT launches ACCEL grants program to improve access to care for people with Sickle cell diseaseGlobal Blood Therapeutics, Inc. (GBT) to...